Healx
Business Services · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
66-68 Hills Rd, Cambridge, Cambridgeshir...Phone Number
+44 1223901980Website
www.healx.ioRevenue
$11.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Healx
Healx is a generative AI enabled, clinical-stage, rare disease biotech pioneering the next generation of drug discovery in order to bring novel, effective treatments to rare disease patients around the world.Explore more
Healx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Healx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Healx has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Healx had a recent Job posting/layoffs
Check out if Healx is spiking on competitors!
Product Launch: Get notified when Healx launches new products
Congratulate Masked Content for being promoted to Masked Content at Healx
Earning: See what the market has to say on Healx recently announced quarterly report
Healx, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Healx has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Healx
Find 2 more new buyers
Compare Similar Companies to Healx
Compare insights from companies similar to Healx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Healx is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Healx is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Healx.
Healx financials insights
Gather financial insights about Healx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Unspecified
$1.7M
2018
Series A
$10M
2024
Series C
$47M
Healx Tech Stack
A closer look at the technologies used by Healx
See more technologies
Most Recent Scoops
Funding
Funding
Open Position
Left Company
Executive Move
Open Position
Open Position
Healx News & Media
Healx Appoints Christopher Moertel, M.D., as Global Head of Clinical Development
Healx, a leading AI-driven drug discovery company focused on rare diseases, announces Christopher Moertel, M.D., as Global Head of Clinical Development CAMBRIDGE, UNITED KINGDOM, May 6, 2025 /EINPresswire.com/ -- Healx, a leading AI-driven drug …Healx Announces First Patient Dosed in Phase 2 Trial Evaluating HLX-1502 for the Treatment of Neurofibromatosis Type 1
CAMBRIDGE, England--(BUSINESS WIRE)--Healx, an AI-enabled, clinical-stage biotech company dedicated to rare diseases, today announced the first patient has been dosed in INSPIRE-NF1, a Phase 2 trial evaluating the safety and efficacy of HLX-1502, an oral investigational therapy, in patients with neurofibromatosis type 1 (NF1). NF1 is a debilitating rare genetic disorder that causes tumours to form along nerves, often manifesting in childhood. It affects approximately one in 2,500 individuals woJonathan Milner, Ph.D., Appointed as Non-Executive Chairman of Healx
CAMBRIDGE, England--(BUSINESS WIRE)--Healx, an AI-enabled, clinical-stage biotech company specialising in rare diseases, today announced the appointment of Jonathan Milner, Ph.D., as the new non-executive chairman of the board, effective immediately. This transition comes as current chairman and co-founder David Brown, Ph.D., begins a secondment to pursue academic research at Trinity College, Cambridge University. While pursuing his studies, Dr. Brown will remain an active member of the Healx bHealx announces agreement with Sanofi to seek new rare disease indications for compound using AI drug discovery platform
CAMBRIDGE, England--(BUSINESS WIRE)--Healx, an AI-enabled, clinical-stage biotech company specialising in rare diseases, today announced it will use a Sanofi compound to identify new disease indications using Healnet, Healx’s AI-driven drug discovery platform. Under the agreement, Sanofi will provide data related to a late stage discontinued asset that is being considered for out-licensing. Financial terms of the partnership are not disclosed. “Today, only 5% of rare diseases have an approved t
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Healx
Sign Up For FreeTo access detailed company insights
Healx is a generative AI enabled, clinical-stage, rare disease biotech pioneering the next generation of drug discovery in order to bring novel, effective treatments to rare disease patients around the world.... Read More
